If you’d like to think that the risk of transvaginal mesh complications is remote, you can, but the Food and Drug Administration (FDA) will disagree with you. In fact, the FDA has taken the unusual step of writing in bold text that serious complications associated with surgical transvaginal repairs of pelvic organ prolapse (POP) were “not rare.”
Pelvic organ prolapse and stress urinary incontinence (SUI) are not uncommon ailments, particularly for women who have recently given birth or experienced menopause. However, reports of transvaginal mesh complications are common. In simple terms, the tragic reality is that the medical device community has manufactured a product in transvaginal mesh devices that exposes patients to serious potential injury.
Have you suffered unexpected pain and discomfort as a result of your transvaginal mesh operation? That’s not the way surgery is supposed to be. It may be time to talk to the legal experts at Nachawati Law Group to find out if you have a viable claim under the law. Based on the fail rate of transvaginal mesh operations, many patients have valid causes of action. Find out everything you need to know by contacting us today.
———
About Nachawati Law Group
Nachawati Law Group represents parties in mass tort litigation, businesses and governmental entities in contingent litigation, and individuals in complex personal injury litigation. For more information, visit contact or call 214-890-0711.
